Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy Robitaille

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Transfusion|October 22, 2020
Transfusion-related Epstein-Barr virus (EBV) infection: A multicenter prospective cohort study among pediatric recipients of hematopoietic stem cell transplants (TREASuRE study)Pascal R Enok Bonong, Chantal Buteau, Gilles Delage, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|September 12, 2025
Pilot-Optimizing Transfusion Therapy in Critically Ill Children With Anemia: A Pilot Multicenter Electronic Health Record-Enabled Randomized Controlled Trial on Red Blood Cell Transfusion in Critically Ill ChildrenMarisa Tucci, Avishay Sarfatti, Stéphane Leteurtre, et al.
European Journal of Haematology|April 8, 2026
Steroid Responsiveness and Clinical Outcomes in Diamond-Blackfan Anemia: Analysis From the Canadian Inherited Marrow Failure RegistryYoung Bae Choi, Rinu Mathew, Hongbing Li, et al.
Transfusion|March 21, 2024
Quality of life and cost-effectiveness of convalescent plasma compared to standard care for hospitalized COVID-19 patients in the CONCOR-1 trialPreston Tse, Jiajun Yan, Yang Liu, et al.
The New England Journal of Medicine|December 9, 2015
A Multinational Trial of Prasugrel for Sickle Cell Vaso-Occlusive EventsMatthew M Heeney, Carolyn C Hoppe, Miguel R Abboud, et al.
Blood|December 12, 2019
Lack of the multidrug transporter MRP4/ABCC4 defines the PEL-negative blood group and impairs platelet aggregationSlim Azouzi, Mahmoud Mikdar, Patricia Hermand, et al.
Transfusion|July 11, 2025
ABO-mismatched platelet and plasma transfusion practices and the potential for transfusion-related alpha-gal syndrome: The Biomedical Excellence for Safer Transfusion Collaborative StudyNancy M Dunbar, Richard M Kaufman, Karina S Bary, et al.
Vox Sanguinis|November 27, 2020
Vox Sanguinis International Forum on Mitigation Strategies to Prevent Faint and Pre-faint Adverse Reactions in Whole Blood Donors: SummaryMindy Goldman, Mary Townsend, Karin Magnussen, et al.
Nature Medicine|January 13, 2022
Author Correction: Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trialPhilippe Bégin, Jeannie Callum, Erin Jamula, et al.
Nature Medicine|September 10, 2021
Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trialPhilippe Bégin, Jeannie Callum, Erin Jamula, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Transfusion|October 22, 2020
Transfusion-related Epstein-Barr virus (EBV) infection: A multicenter prospective cohort study among pediatric recipients of hematopoietic stem cell transplants (TREASuRE study)Pascal R Enok Bonong, Chantal Buteau, Gilles Delage, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|September 12, 2025
Pilot-Optimizing Transfusion Therapy in Critically Ill Children With Anemia: A Pilot Multicenter Electronic Health Record-Enabled Randomized Controlled Trial on Red Blood Cell Transfusion in Critically Ill ChildrenMarisa Tucci, Avishay Sarfatti, Stéphane Leteurtre, et al.
European Journal of Haematology|April 8, 2026
Steroid Responsiveness and Clinical Outcomes in Diamond-Blackfan Anemia: Analysis From the Canadian Inherited Marrow Failure RegistryYoung Bae Choi, Rinu Mathew, Hongbing Li, et al.
Transfusion|March 21, 2024
Quality of life and cost-effectiveness of convalescent plasma compared to standard care for hospitalized COVID-19 patients in the CONCOR-1 trialPreston Tse, Jiajun Yan, Yang Liu, et al.
The New England Journal of Medicine|December 9, 2015
A Multinational Trial of Prasugrel for Sickle Cell Vaso-Occlusive EventsMatthew M Heeney, Carolyn C Hoppe, Miguel R Abboud, et al.
Blood|December 12, 2019
Lack of the multidrug transporter MRP4/ABCC4 defines the PEL-negative blood group and impairs platelet aggregationSlim Azouzi, Mahmoud Mikdar, Patricia Hermand, et al.
Transfusion|July 11, 2025
ABO-mismatched platelet and plasma transfusion practices and the potential for transfusion-related alpha-gal syndrome: The Biomedical Excellence for Safer Transfusion Collaborative StudyNancy M Dunbar, Richard M Kaufman, Karina S Bary, et al.
Vox Sanguinis|November 27, 2020
Vox Sanguinis International Forum on Mitigation Strategies to Prevent Faint and Pre-faint Adverse Reactions in Whole Blood Donors: SummaryMindy Goldman, Mary Townsend, Karin Magnussen, et al.
Nature Medicine|January 13, 2022
Author Correction: Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trialPhilippe Bégin, Jeannie Callum, Erin Jamula, et al.
Nature Medicine|September 10, 2021
Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trialPhilippe Bégin, Jeannie Callum, Erin Jamula, et al.
Pageof 7